BC Platforms launches an end-to-end solution for precision medicine Microsoft genomic service

BC Platforms announces it has launched GeneVision, a new end-to-end solution for precision medicine that uses the Microsoft Genomics service which runs on Microsoft Azure. GeneVision provides end-to-end software-as-a-service solution from raw genome data to patient reports, implemented using Azure services. GeneVision utilizes several of BC Platforms existing pipeline technologies and offers scalable, easy-to-use workflows for both genotyping and next-generation sequencing, data quality monitoring, and production of different patient reports for precision medicine.

Many healthcare institutions are currently shaping their genomic healthcare strategy, and designing their approach for transforming their operations from the use of individual genetic tests to larger data production and broader genetically assisted decision making on a population level.

“Our technology is focused on using the insight and knowledge-driven from genomics to contribute to better and more personalized healthcare outcomes to patients,” says Tero Silvoa, CEO of BC Platforms. “BC Platforms’ GeneVision platform, that uses the Microsoft Genomics service, which runs on Microsoft Azure, delivers accurate, actionable and secure clinical insight at the point of care.”

This does, however, create new challenges for healthcare providers due to the sheer quantity of data being compiled and the complexity. These challenges include the design and provision of most scalable and cost-effective solutions for future large-scale genome data production and quality control, scalable IT environment for genome data handling, and finding the streamlined solution for genomic result interpretation and delivery to clinician making decisions in patient care. GeneVision has been launched by BC Platforms to serve this need.

“GeneVision can help healthcare professionals expand the role of genomics beyond rare diseases and oncology, towards producing NGS and Genotyping data at scale and expanding its application beyond research use,” says Geralyn Miller, director, Microsoft Genomics. “We are very excited to be part of this transformation together with our partner BC Platforms, and enable the ability for customers to incorporate precision medicine practices into their organizations, at a large scale.”

Be the first to comment

Leave a Reply

Your email address will not be published.